Yuki Gosei Kogyo Co., Ltd. researches, develops, manufactures, and markets amino acids, chemical products, and pharmaceuticals in Japan and internationally. It offers food additives, and industrial and agricultural chemicals; and glycine, glycine compounds, nicotinic acid amide, active pharmaceutical ingredients, nicotinamide, isoniazid, drug intermediates, and cosmetic ingredients. The company also provides pyridine, piperidine, silicon, and other compounds; DNA, nucleoside, and protamine; and active pharmaceutical ingredients. In addition, it engages in the contract manufacturing of pharmaceuticals and chemical products. Yuki Gosei Kogyo Co., Ltd. was incorporated in 1947 and is headquartered in Chuo, Japan.
Research context
Yuki Gosei Kogyo Co., Ltd appears in PyInvesting’s Tokyo Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- JPY
- Sector
- Basic Materials
- Industry
- Chemicals
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Yuki Gosei Kogyo Co., Ltd is currently in a long term uptrend where the price is trading 16.8% above its 200 day moving average.
From a valuation standpoint, the stock is 7.4% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 0.7.
Yuki Gosei Kogyo Co., Ltd's total revenue sank by 26.5% to $2B since the same quarter in the previous year.
Its net income has dropped by 525.9% to $-115M since the same quarter in the previous year.
Based on the above factors, Yuki Gosei Kogyo Co., Ltd gets an overall score of 2/5.